Author

Umasankar De

University of FloridaORCID 0000-0003-4478-791XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Umasankar De1 paper · University of Florida Health

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Weizhou ZhangiD· 2 shared Adriaan W. BruijnzeeliD· 1 shared Alberto RivaiD· 1 shared Alexander Scala· 1 shared Allison M. Lynch· 1 shared Amin SobhiD· 1 shared Amy Fagan· 1 shared Benjamin G. BarwickiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Weizhou ZhangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyACS Pharmacology & Translational SciencePeer-reviewedOct 2, 2024

AB-free kava enhances resilience against the adverse health effects of tobacco smoke in mice

Tengfei Bian, Allison M. Lynch, Kayleigh Ballas…·Chengguo Xing

This study evaluates AB-free kava's effects on tobacco smoke-exposed mice, showing it mitigates health deficits with safety, suggesting potential for reducing tobacco-related harm.

6 citations

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBloodPeer-reviewedJul 24, 2024

KDM6A Regulates Immune Response Genes in Multiple Myeloma

Daphné Dupéré-Richer, Alberto Riva, Sayantan Maji…·Jonathan D. Licht

This study shows KDM6A regulates immune response genes in multiple myeloma by activating NLRC5 and CIITA, and its loss reduces MHC expression, which can be reversed by HDAC3 inhibitors.

23 citationstop 2%

𝕏 PostBluesky